// App-Quantinova.ai

: Lenalidomide As Maintenance Treatment for Patients with Newly Diagnosed Multiple Myeloma Post-Autologous Stem Cell Transplantation: A Pharmacoeconomic Assessment in the Netherlands

Researchers

Presenter

  • Carin A. Uyl-de Groot

Principal Investigators

  • Rachel Ramsden

  • Janneke Boersma

  • Sonja Zweegman

  • Sujith Dhanasiri

Medical Centers

  • Institute of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, Netherlands

  • BresMed Health Solutions, Sheffield, United Kingdom

  • Cergentis BV, Utrecht, Netherlands

  • Department of Medical Oncology, VU University Medical Center, Amsterdam, Netherlands

  • Celgene International Sarl, Boudry, Switzerland

Locations

  • Netherlands

  • United Kingdom

  • Switzerland

Companies

  • BresMed Health Solut

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • N/A

Drug/Treatment

  • Lenalidomide

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved